An In Vitro System for Studying Toxin Transport Across Hemodialysis Membranes

Area of Science:

• Biomedical Engineering
• Nephrology
• Materials Science

Background:

• Chronic kidney disease (CKD) progresses to end-stage kidney disease (ESKD), necessitating renal replacement therapy like hemodialysis (HD).
• Current HD membranes struggle to efficiently remove middle-sized molecules and protein-bound uremic toxins.
• Varied experimental conditions in studies hinder direct comparison of novel HD membrane performance.

Purpose of the Study:

• To develop a standardized in vitro system for evaluating diverse hemodialysis membranes.
• To enable direct comparison of membrane performance under consistent hemodialysis conditions.
• To assess the efficacy of novel mixed matrix membranes (MMM) against commercial membranes.

Main Methods:

• Developed an in vitro system using a mini dialyzer with FX1000 and mixed matrix membranes (MMM).
• Utilized model uremic toxins: creatinine (Cr), hippuric acid (HA), and indoxyl sulfate (IS).
• Assessed toxin removal in human plasma and blood, employing dialysate recirculation for mass balance and normalized dialysance (DL) for performance evaluation.

Main Results:

• The developed in vitro system accurately assessed toxin removal by both commercial and novel membranes.
• Dialysate recirculation enabled precise estimation of toxin mass balance and analysis of transport phenomena.
• Normalized dialysance (DL) proved effective in evaluating membrane performance across various conditions.

Conclusions:

• The established in vitro system provides a reliable platform for evaluating hemodialysis membranes.
• This system facilitates the direct comparison of commercial and developmental hollow fiber membranes for HD.
• The findings support the use of this system for advancing hemodialysis membrane technology and improving patient outcomes.